Correction -- bellicum reports inducement grants under nasdaq listing rule 5635(c)(4)

Houston, jan. 31, 2023 (globe newswire) -- in a release issued earlier today by bellicum pharmaceuticals, inc. (nasdaq:blcm), please note that the total number of stock options should be 20,000, not 45,000, as previously stated. the corrected release follows:

BLCM Ratings Summary

BLCM Quant Ranking